Innovation Driven Quality FirstAn integrated preclinical evaluation service platform satisfying international applications
Company Profile

ZSHK Laboratories Limited is a biopharmaceutical pre-clinical research and development service company mainly engaged in pre-clinical research and evaluation services for drugs and medical devices. As a one-stop evaluation and research service platform, it provides services including pharmacology, pharmacodynamics, pharmacokinetics, toxicology and other safety-related studies for pharmaceutical developers and researchers worldwide.

 

ZSHK has established independent laboratories in Pingshan District of Shenzhen, Guangdong Province, and Suzhou Industrial Park and Suzhou New District, Jiangsu Province. ZSHK also jointly operated the Drug Safety Testing Center in Hong Kong Science Park with Hong Kong Science and Technology Parks Corporation. Paying active efforts in supply chain deploying, ZSHK has established breeding and research bases of experimental dogs and non-human primates in Hunan and Guangxi.

 

View More+
Development History

ZSHK Laboratories Limited, originated from Center for Drug Safety Evaluation and Research (CDSER) of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, has core members engaged in drug safety evaluation and research for more than 20 years. Key members of the company have a long history of services in CDSER. Our consultant team is composed of members of the Chinese Academy of Engineering and the Chinese Academy of Sciences, US FDA drug evaluation officers, GLP inspectors, former senior pathologists of AstraZeneca, and senior safety pharmacology experts.

2023
2023 In April, AnLing Biomed (Shenzhen) Co., Ltd. obtained GLP certification from NMPA.
2023
2023 In February, AnLing Biomed (Suzhou) Co., Ltd. gained expanded GLP accreditation from NMPA.
2022
2022 In October, AnLing Biomed (Shenzhen) Co., Ltd. was granted full accreditation from AAALAC International.
2021
2021 In December, AnLing Biomed (Shenzhen) Co., Ltd. obtained Laboratory Animal Use Certification.
2021
In September, AnLing Biomed (Suzhou) Co., Ltd. obtained pharmaceutical GLP certification approval from NMPA
2021
In August, our non-human primate breeding and research base in Guangxi was established
2020
In August, our experimental dog breeding and research base in Hunan was established
2020
In April, AnLing Biomed (Shenzhen) Co., Ltd. was established
2019
In October, ZSHK took over the preparation and establishment of the Hong Kong Science Park Drug Safety Evaluation Center
2019
In October, ZSHK Laboratories Limited was incorporated in Hong Kong
2017
In May, AnLing Biomed (Suzhou) Co., Ltd. was established
2001
Shanghai Institute of Materia Medica, Chinese Academy of Sciences established Center for Drug Safety Evaluation and Research
Partner

Copyright © AnLing Biomed (Suzhou) Co., Ltd. All Rights Reserved Source：Boooming ICP：粤ICP备2022021434号-2 CNZZ